Rxsight Stock Price Prediction

RXST Stock  USD 44.83  0.22  0.49%   
At this time, the relative strength index (RSI) of Rxsight's share price is approaching 40 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Rxsight, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
The successful prediction of Rxsight's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Rxsight, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Rxsight's stock price prediction:
EPS Estimate Next Quarter
(0.18)
EPS Estimate Current Year
(0.07)
EPS Estimate Next Year
0.206
Wall Street Target Price
63
EPS Estimate Current Quarter
(0.25)
Using Rxsight hype-based prediction, you can estimate the value of Rxsight from the perspective of Rxsight response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Rxsight to buy its stock at a price that has no basis in reality. In that case, they are not buying Rxsight because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Rxsight after-hype prediction price

    
  USD 45.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Rxsight Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rxsight's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
37.7240.0449.56
Details
Naive
Forecast
LowNextHigh
41.7244.0446.35
Details
9 Analysts
Consensus
LowTargetHigh
30.7633.8037.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.020.02
Details

Rxsight After-Hype Price Prediction Density Analysis

As far as predicting the price of Rxsight at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rxsight or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Rxsight, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Rxsight Estimiated After-Hype Price Volatility

In the context of predicting Rxsight's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rxsight's historical news coverage. Rxsight's after-hype downside and upside margins for the prediction period are 42.73 and 47.37, respectively. We have considered Rxsight's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
44.83
45.05
After-hype Price
47.37
Upside
Rxsight is very steady at this time. Analysis and calculation of next after-hype price of Rxsight is based on 3 months time horizon.

Rxsight Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Rxsight is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rxsight backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rxsight, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.32 
2.32
  1.33 
  0.09 
10 Events / Month
11 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
44.83
45.05
0.00 
55.90  
Notes

Rxsight Hype Timeline

Rxsight is at this time traded for 44.83. The entity has historical hype elasticity of -1.33, and average elasticity to hype of competition of -0.09. Rxsight is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 55.9%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.32%. %. The volatility of related hype on Rxsight is about 857.27%, with the expected price after the next announcement by competition of 44.74. About 90.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Rxsight recorded a loss per share of 0.81. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 10 days.
Check out Rxsight Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Rxsight Related Hype Analysis

Having access to credible news sources related to Rxsight's direct competition is more important than ever and may enhance your ability to predict Rxsight's future price movements. Getting to know how Rxsight's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rxsight may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AXGNAxogen Inc 0.49 9 per month 3.80 (0.01) 4.73 (5.50) 21.60 
TMCITreace Medical Concepts 0.08 10 per month 2.76  0.06  6.08 (4.39) 38.73 
LUNGPulmonx Corp(0.50)8 per month 0.00 (0.04) 9.00 (6.89) 20.52 
OFIXOrthofix Medical 0.12 9 per month 2.04  0.04  3.90 (3.85) 12.11 
KIDSOrthopediatrics Corp(0.88)11 per month 0.00 (0.09) 5.04 (5.08) 19.39 
SGHTSight Sciences(0.05)8 per month 0.00 (0.20) 6.96 (7.84) 18.22 
FNAParagon 28 0.25 7 per month 4.04  0.07  7.83 (6.30) 43.16 
SSKNSTRATA Skin Sciences(0.03)10 per month 3.83  0.05  8.83 (7.20) 20.44 
NPCENeuropace(0.25)10 per month 3.21  0.06  9.73 (6.19) 35.38 
VAPOVapotherm 0.00 0 per month 0.00 (0.05) 15.38 (11.63) 34.31 
TLISTalis Biomedical Corp 0.00 0 per month 0.00 (0.19) 5.32 (10.69) 68.77 
VREXVarex Imaging Corp 0.22 10 per month 2.89  0.12  7.07 (5.05) 18.78 
APYXApyx Medical 0.04 7 per month 3.26  0.04  9.38 (6.45) 32.02 
SIBNSi Bone 0.36 11 per month 0.00 (0.08) 6.75 (4.54) 27.00 
IRMDIradimed Co(4.71)9 per month 1.70  0.08  3.26 (2.53) 11.03 
CVRXCVRx Inc 0.53 9 per month 3.55  0.15  12.31 (8.22) 41.08 

Rxsight Additional Predictive Modules

Most predictive techniques to examine Rxsight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rxsight using various technical indicators. When you analyze Rxsight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Rxsight Predictive Indicators

The successful prediction of Rxsight stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rxsight, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rxsight based on analysis of Rxsight hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rxsight's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rxsight's related companies.
 2021 2022 2023 2024 (projected)
Payables Turnover10.710.679.147.01
Days Of Inventory On Hand162.19195.64180.07312.42

Story Coverage note for Rxsight

The number of cover stories for Rxsight depends on current market conditions and Rxsight's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rxsight is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rxsight's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Rxsight Short Properties

Rxsight's future price predictability will typically decrease when Rxsight's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rxsight often depends not only on the future outlook of the potential Rxsight's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rxsight's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.5 M
Cash And Short Term Investments127.2 M

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.